The third interactive case study describes patient follow-up after bilateral adrenalectomy and explains how to develop a treatment plan for an aggressive Nelson’s tumour.

Using strict biochemical thresholds for the diagnosis of patients with suspected Cushing’s disease could help improve diagnostic accuracy, report Daniel Kelly and co-authors.

The selective glucocorticoid receptor modulator relacorilant may warrant further investigation for the treatment of endogenous Cushing’s syndrome, suggest phase 2 trial results published in Frontiers in Endocrinology in July 2021.